Global Dermatophytic Onychomycosis Therapeutics Market Expected to Touch a Value of US $6,741.6 Mn by 2026
Increased prevalence of chronic lifestyle maladies such as diabetes heightens dermatophytic onychomycosis prevalence amongst older generation thus necessitating advancements in dermatophytic onychomycosis therapeutics development. Characterized by brittle, discolored nails, the condition often results in acute pain in toenails as well as finger nails alike.
View full press release